Patent · US Active

Hepatitis C therapies

US8163703B2 · kind B2 · utility

18Cited by

4References

31Claims

0Family size

Assignee

BioCryst Pharmaceuticals, Inc. · US

Inventors

Yarlagadda S. Babu · Birmingham, US
Pooran Chand · Birmingham, US
Minwan Wu · Vestavia Hills, US
Pravin L. Kotian · Hoover, US
V. Satish Kumar · Birmingham, US
Tsu-Hsing Lin · Vestavia Hills, US
Yahya El-Kattan · Hoover, US
Ajit K. Ghosh · Birmingham, US

Key dates

Filing date	Mar 6, 2009
Grant date	Apr 24, 2012
Priority date	—
Expiry date	Apr 24, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides methods for treating hepatitis C viral infections and related viral infections, as well as compounds and compositions that are useful for treating such infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.